58F-32473-06604
4 vaccinations
2 coded responses
39 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 287 / NC
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-21
-
2021-01-27
Dose 2 — Pfizer-BioNTech
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
-
2021-02-24
Survey response — day 28, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throat for approximately 8 hours for unknown reason during the late evening/overnight on February 18th, 2021. It resolved on its own.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-10
- 2021-04-28
- 2021-07-28
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-02
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-12-31
-
2022-04-01
Survey response — 6 months, dose 3MedDRA: Hypertension, Office visit, SARS-CoV-2 test positive, Tachycardia, Urticaria — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: I tested positive for Covid on 2-4-22. After covid I developed hives, HTN, & tachycardia. The hives resolved in 8 days & with treatment. I am currently on a medication for the HTN & tachycardia. Both of these conditions are currently stable. · Healthcare visit (other): Primary care dr. visitMedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-05
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-08-15
Dose 4 — Pfizer-BioNTech
- 2023-02-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-08-15 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 4 — day 28, dose 2
Symptoms: Sore throat for approximately 8 hours for unknown reason during the late evening/overnight on February 18th, 2021. It resolved on its own.
Release 11 — 6 months, dose 3
Symptoms: I tested positive for Covid on 2-4-22. After covid I developed hives, HTN, & tachycardia. The hives resolved in 8 days & with treatment. I am currently on a medication for the HTN & tachycardia. Both of these conditions are currently stable.
Healthcare visit (other): Primary care dr. visit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release